MYCN and adrenal gland neoplasm: The occurrence of MYCN amplification in approximately 20% of neuroblastomas, which correlates with high-risk disease and poor prognosis (11), further underscores the importance of MYC and HIF signaling pathways in these adrenal neoplasms derived from the neural crest.